Look up the FDA’s Food Traceability List and you will find shell eggs, soft cheese, shrimp, oysters and fresh-cut melon. You will not find cultivated meat. You will not find precision-fermented protein. Neither is named, referenced, or implied anywhere in the rule that food-safety teams treat as the traceability baseline for anything “high-risk.”
That is not an oversight — the list was built before either category existed at commercial scale, and nothing about the rule’s design updates it automatically as new products appear. But it means a compliance assumption we have heard operators make out loud — “we’ll be ready for FSMA 204” — is often the wrong regulatory framework entirely for these two product categories. Something else governs them. This is what that something else actually requires, and where it is looser, tighter, or simply different from what FSMA 204 would have demanded.
What FSMA 204 actually covers
The Food Traceability Rule — Section 204 of the FDA Food Safety Modernization Act, finalized November 21, 2022 — applies only to foods on the Food Traceability List (FTL), a defined set the FDA designated by risk. The FTL covers shell eggs; soft, semi-soft and fresh cheeses (not aged or hard cheeses); finfish, crustaceans and mollusks; certain fresh produce; nut butters; and a handful of other specific categories. Foods on the list carry real obligations: a written Traceability Plan, assigned Traceability Lot Codes, Key Data Elements captured at each Critical Tracking Event — packing, shipping, receiving, transformation — and the ability to hand FDA the relevant records within 24 hours of a request.
Compliance was originally due January 20, 2026. The FDA proposed extending that by 30 months to July 20, 2028, citing industry feedback that data systems for sharing lot codes across supply-chain partners were not yet interoperable; Congress separately directed FDA, via the Continuing Appropriations Act of 2026, not to enforce the rule before that date. Practically, July 2028 is the date to plan around regardless of which mechanism ultimately governs it.
None of this reaches cultivated meat or precision-fermented protein, because neither appears on the FTL and the FTL is the rule’s entire scope. A company producing either is not “behind” on FSMA 204 compliance — it is simply not a covered entity for this specific rule, for either its finished product or (in most cases — see below) its raw ingredient inputs.
What governs cultivated meat instead
Cultivated meat runs on a framework FDA and USDA-FSIS built specifically for it, formalized in a March 2019 agreement, well before FSMA 204’s own November 2022 final rule existed. The split: FDA oversees cell collection, cell banking, and growth and differentiation of the cells. USDA-FSIS takes over at harvest — the point where cells are removed from the cultivator — through processing, packaging and labeling, for livestock, poultry and catfish species. FDA retains labeling authority over other cultivated seafood and game meat.
The traceability-relevant obligations sit on the USDA-FSIS side. FSIS inspectors review the batch records generated during cell culturing, and — the detail worth underlining — inspect facilities at least once per operating shift, the same frequency required for conventional meat and poultry processing. FSMA 204’s Critical Tracking Events are triggered by specific supply-chain moments: a shipment, a receipt, a transformation step. USDA-FSIS’s inspection regime is continuous and calendar-driven regardless of whether product is moving. That is a materially different traceability architecture, not an absence of one.
The practical consequence: a cultivated-meat producer preparing for “traceability compliance” should be building batch-record systems and HACCP documentation to FSIS inspection standards, not FSMA 204’s lot-code and 24-hour-production framework. The two regimes ask for different artifacts, on different timelines, verified by different agencies. Building for the wrong one wastes engineering effort that the actual inspector will not credit.
Labeling carries its own separate obligation that has no FSMA 204 analog at all: every cultivated meat or poultry label must be individually pre-approved by FSIS before the product can be sold, the same requirement that applies to conventional meat and poultry labels. FSIS’s current working guidance requires “cell-cultivated” or “cell-cultured” to appear in the product name, in text no smaller, less prominent or differently colored than the rest of the name.
What governs precision-fermented protein ingredients
Precision-fermented proteins — the whey, egg and other proteins produced by engineered microorganisms and cleared through the FDA’s GRAS pathway, which we mapped in full separately — sit in a plainer position. They are food ingredients, full stop, regulated the way any other GRAS ingredient is: current Good Manufacturing Practice compliance, a hazard analysis with preventive controls for each facility, a recall plan, and ordinary recordkeeping under 21 CFR Part 117. None of that is FTL-specific, because the ingredient itself is not an FTL food and — in most cases — is not an ingredient of an FTL food either.
There is a real edge case worth naming precisely rather than glossing over. FSMA 204 traces Critical Tracking Events for FTL-listed foods used as ingredients in other products, not only for the finished retail item. A precision-fermented protein is not itself on the list under any circumstance. But if that protein is formulated into a finished product that itself matches an FTL category by definition — a fermentation-derived “soft cheese” alternative, for instance, positioned and sold as soft cheese — it is a live, unresolved question whether the finished product would be swept in by the FTL’s category-based definition regardless of its animal-free protein source. We could not find FDA guidance that resolves this scenario directly, and it should be confirmed with FDA or qualified regulatory counsel before assuming either answer for a specific product. Treat this as the single highest-value open question for any formulator building toward a category the FTL already names.
Side by side
| FSMA 204 (Food Traceability Rule) | Cultivated meat (USDA-FSIS) | Precision-fermented protein ingredients | |
|---|---|---|---|
| Legal basis | FSMA Section 204, final rule Nov 2022 | 2019 FDA-USDA formal agreement; FMIA/PPIA | Standard GRAS/food-additive framework |
| Trigger | Product appears on the Food Traceability List | Any cell-cultured livestock, poultry or catfish product | N/A — ordinary ingredient recordkeeping |
| Core mechanism | Lot codes + Key Data Elements at Critical Tracking Events | Batch-record review + inspection at least once per shift | CGMP + hazard analysis + recall plan |
| Records on demand | Yes — within 24 hours of FDA request | Yes — via routine, continuous FSIS inspection | Yes — under standard Part 117 recordkeeping |
| Label pre-approval | Not required by this rule | Mandatory, product-by-product, before sale | Not required by this rule |
| Compliance date | January 20, 2026 — unchanged; enforcement barred until July 20, 2028 by appropriations rider | Already in force | Already in force |
The counter-argument
It would be easy to read “not on the FTL” as “less regulated,” and that framing overstates the case. The FTL exists to add recordkeeping burden on top of the food safety rules that already apply to everyone — it is an enhancement layer for specific outbreak-prone categories, not the floor of food safety regulation itself. Cultivated meat sits under a continuous, per-shift federal inspection regime that most conventional food categories, FTL-listed or not, do not receive; precision-fermented ingredients answer to the same CGMP and recordkeeping baseline every food ingredient does. Neither category is operating in a traceability vacuum. The accurate statement is narrower than “unregulated”: these two categories are traced through mechanisms that predate FSMA 204 and were not designed with them in mind, rather than through the rule built most recently and most visibly for that exact purpose.
What we could not establish
Whether a finished product using a precision-fermented protein, formulated and marketed to match an FTL category by definition (soft cheese, in particular), would be brought into FSMA 204’s scope by that categorization despite its non-animal protein source — flagged above as unresolved and worth direct confirmation before relying on either assumption.
Whether FDA has any current internal timeline for evaluating cultivated meat or precision-fermented protein for future FTL inclusion as volumes grow — no such proposal or advance notice was found in the sources reviewed for this piece.
The final legal mechanism governing the July 20, 2028 compliance date with full certainty — this piece relies on FDA’s own proposed rule plus the separately reported congressional appropriations directive; we did not locate a single document that definitively closes out whether FDA’s proposed rule itself has been finalized as of this writing, as distinct from the date being enforced via the appropriations rider. (Resolved 6 September 2026: it has not been finalized. RIN 0910-ZC21 carries one Federal Register document, the proposal. The compliance date remains January 20, 2026 — see FSMA 204’s compliance date never moved.)
What to watch
Whether FDA opens a formal FTL update process that names cultivated products. The FTL has been amended before by rulemaking; as commercial volumes for cultivated meat and precision-fermented protein grow, and if either develops an outbreak or recall history, risk-based criteria could eventually justify inclusion. Nothing in current public documentation suggests this is imminent.
FSIS’s promised labeling rulemaking. FSIS has stated it intends to publish new, formal labeling regulations for cell-cultured meat and poultry, rather than continuing to rely on case-by-case guidance. A finalized rule could adjust documentation requirements alongside labeling.
The July 2028 date itself. Thirty-month extensions of federal compliance deadlines are not guaranteed to hold to the day; the same stakeholder pressure that produced this extension could produce another if supply-chain data systems remain unready as the date approaches.